A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1994
12/22/1994	CA2164632A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
12/22/1994	CA2164606A1 Compositions for use in the regulation of subnormal ph values in the intestinal tract and for treatment of bowel diseases
12/22/1994	CA2161811A1 Human metabotropic glutamate receptors, nucleic acids encoding same and uses thereof
12/22/1994	CA2160368A1 Preparations containing silicon dioxide to improve the taste thereof
12/21/1994	EP0629408A1 Combination of angiotensin converting enzyme inhibitors and AII antagonists
12/21/1994	EP0610368A4 Treatment of acne or of pseudofolliculitis barbae.
12/20/1994	US5374635 Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis
12/15/1994	CA2124912A1 Therapeutic composition
12/14/1994	EP0628313A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with dinretics or calcium antagonists
12/14/1994	EP0628305A1 Stable oil-in-water emulsion type cosmetic or dermatologic composition containing at least one vegetable oil comprising at least 40% triglycerides derived from linolic acid
12/14/1994	EP0627940A1 Diagnostic and/or therapeutic agents, targeted to neovascular endothelial cells
12/14/1994	EP0627917A1 Cytoprotective compositions containing pyruvate and antioxidants
12/13/1994	US5373022 Salts/ion pairs of non-steroidal anti-inflammatory drugs in various dosage forms
12/13/1994	US5373021 Rapid diffusion injectable formulation
12/13/1994	US5373005 Despiramine in the treatment of drug-resistant malarial infections
12/13/1994	US5372812 Composition and method for acceleration of clot lysis
12/13/1994	US5372808 Methods and compositions for the treatment of diseases with consensus interferon while reducing side effect
12/08/1994	WO1994028000A1 Calanolide and related antiviral compounds, compositions, and uses thereof
12/08/1994	WO1994027642A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them
12/08/1994	WO1994027603A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	WO1994027590A1 New procedure to block the replication of reverse transcriptase dependent viruses by the use of inhibitors of deoxynucleotides synthesis
12/08/1994	WO1994027586A1 Inhibition of hair growth
12/08/1994	WO1994027585A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	WO1994027583A2 Apoptosis inhibitors for treating neurodegenerative diseases
12/08/1994	WO1994027563A1 Inhibition of hair growth
12/08/1994	WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases
12/08/1994	CA2163966A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders
12/08/1994	CA2163638A1 Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders
12/08/1994	CA2141028A1 Hepatotropic conjugates of antiviral drugs, carriers thereof and pharmaceutical compositions containing them
12/07/1994	EP0626969A1 CoA-IT AND PAF INHIBITORS
12/07/1994	EP0626864A1 Topical composition containing hyaluronic acid and nsaids
12/07/1994	EP0626844A1 Compositions of clindamycin and benzoyl peroxide for acne treatment
12/07/1994	EP0469079B1 Non-absorbable cholesterol esterase inhibitors for decreasing cholesterol absorption
12/07/1994	CA2097892A1 Prevention and control of cancer
11/1994
11/30/1994	EP0626173A1 Aerosol composition containing fusafungine
11/30/1994	EP0625903A1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers
11/30/1994	EP0422164B1 Large multivalent immunogen
11/30/1994	EP0366765B1 Antiglaucoma compositions containing combinations of sympathomimetic agents and beta-1 selective beta-blockers
11/30/1994	CN1095591A Combination of a cholesteral biosynthesis inhibitor and a beta-lactam cholesterol absorption inhibitor
11/29/1994	US5368860 Preparation for transdermal drug administration
11/29/1994	US5368858 Methods and compositions for the treatment and repair of defects or lesions in cartilage
11/29/1994	US5368853 Leukoregulin anti-viral therapy
11/29/1994	CA2124252A1 Method of reducing or preventing bone marrow hypoplasia
11/26/1994	CA2124179A1 New fusafungine-based medicinal spray formulation, a process for its production and pharmaceuticals containing same
11/24/1994	WO1994026717A1 Hiv protease inhibitors useful for the treatment of aids
11/24/1994	WO1994026307A1 Inhibition of migration inhibitory factor in the treatment of diseases involving cytokine-mediated toxicity
11/24/1994	WO1994026303A1 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
11/24/1994	WO1994026298A1 Methods for treating muscle diseases and disorders
11/24/1994	WO1994026297A1 Improved detection and therapy of lesions with biotin/avidin-metal chelating protein conjugates
11/24/1994	WO1994026270A1 Transdermal therapeutic systems for the administration of serotonin agonists
11/24/1994	WO1994026250A1 Method for treating neurological disorders
11/24/1994	WO1994026114A1 Method of stimulating and modulating the immune system of animals with microbial compositions
11/24/1994	CA2161334A1 Hiv protease inhibitors useful in the treatment of aids
11/24/1994	CA2160776A1 Transdermal therapeutic systems for the administration of serotonin agonists
11/23/1994	EP0625150A1 1,3-oxathiolane nucleoside analogues
11/23/1994	EP0625055A1 Use of fullerenes in diagnostic and/or therapeutic agents
11/23/1994	CN1095268A Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366994 Enzyme inhibitors
11/22/1994	US5366967 Potentiation of the anti-reactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
11/22/1994	US5366739 Treating dry eye
11/17/1994	EP0624368A2 Use of a composition for stimulating the synthesis of glutathione in the manufacture of a medicament for the treatment of acquired immune deficiency syndrome
11/17/1994	EP0624096A1 Taxol as a radiation sensitizer
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5364757 Methods of supporting a diagnosis of systemic lupus erythematosus
11/15/1994	US5364644 Calcium or potassium glucarate
11/15/1994	US5364636 Inhibitor of absorption of digestion product of food and drink
11/15/1994	US5364616 Use of H-2 antagonists for treatment of gingivitis
11/11/1994	CA2122814A1 Method for treating acquired immune deficiency syndrome
11/10/1994	WO1994025626A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	WO1994025616A1 Cell-targeted lytic pore-forming agents
11/10/1994	WO1994025027A1 Btp receptor modulator of the gabaa/chloride channel complex for prolonging the duration of the gaba induced membrane current
11/10/1994	WO1994025018A1 Gaba-ergic modulation of eye growth
11/10/1994	WO1994025016A1 Novel medical use for gaba agonists
11/10/1994	CA2162157A1 Polyoxime compounds and their preparation
11/10/1994	CA2161531A1 Dna profiles as an indicator of cellular redox potential and cancer risk
11/10/1994	CA2160909A1 Cell-targeted lytic pore-forming agents
11/09/1994	EP0623146A1 COMPOUNDS AND METHODS FOR INHIBITING $g(b)-PROTEIN FUNCTION
11/09/1994	EP0616493A4 Methods and compositions for reducing multi-drug resistance.
11/09/1994	EP0576612A4 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity.
11/09/1994	EP0420937B1 Therapeutic compositions for the treatment of myocardial infarction
11/09/1994	CN1094642A Therapeutic combination
11/08/1994	CA1332941C N-alkylated quaternary nitrogen containing heterocycles
11/08/1994	CA1332940C N-alkylated quaternary nitrogen-containing heterocycles
11/08/1994	CA1332939C 2,5,6-substituted-n -alkylpyrimidines
11/08/1994	CA1332938C N-alkylated quaternary nitrogen-containing heterocycles
11/02/1994	EP0396560B1 Process for increasing the growth rate and/or utilization of fodder or foodstuffs and/or resistance in animals and humans
11/02/1994	CN1094218A Combating fish parasites
11/01/1994	US5360820 Medical use for tachykinin antagonists
11/01/1994	US5360615 Solvent system enhancing the solubility of pharmaceuticals for encapsulation
11/01/1994	CA1332808C Polyester-based composition for the controlled release of medicinal substances
10/1994
10/27/1994	WO1994024161A1 Novel receptor-type phosphotyrosine phosphatase-kappa
10/27/1994	WO1994023767A1 Oral drug delivery compositions and methods
10/27/1994	WO1994023748A1 Administration of vaso-active agent and therapeutic agent
10/27/1994	WO1994023734A1 Method of treatment of diseases by deletion of t cells
10/27/1994	WO1994023725A1 Compositions, for inhibition, control and regression of angiogenesis, containing hyaluronic acid and nsaid
10/27/1994	WO1994023723A1 Adenosine receptor agonists for the promotion of wound healing
10/27/1994	WO1994023708A1 Use of steroid antagonists for the therapy and prophylaxis of demential illnesses
10/27/1994	CA2161229A1 Novel receptor-type phosphotyrosine phosphatase-kappa
10/27/1994	CA2159891A1 Method of treatment of diseases by deletion of t cells

1 ... 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 ... 1151